CN Patent

CN118159529A — 一种稠合吡啶环衍生物的可药用盐、晶型及其制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2024-06-07 · 2y expired

What this patent protects

本公开涉及一种稠合吡啶环衍生物的可药用盐、晶型及其制备方法。具体而言，本公开涉及如式(I)所示化合物的胆碱盐、钠盐、钾盐、钙盐、精氨酸盐、赖氨酸盐、葡甲胺盐、乙醇胺盐、硫酸氢盐、盐酸盐、酒石酸盐、马来酸盐、柠檬酸盐、苹果酸盐、对甲苯磺酸盐和甲磺酸盐，以及结晶形式。

USPTO Abstract

本公开涉及一种稠合吡啶环衍生物的可药用盐、晶型及其制备方法。具体而言，本公开涉及如式(I)所示化合物的胆碱盐、钠盐、钾盐、钙盐、精氨酸盐、赖氨酸盐、葡甲胺盐、乙醇胺盐、硫酸氢盐、盐酸盐、酒石酸盐、马来酸盐、柠檬酸盐、苹果酸盐、对甲苯磺酸盐和甲磺酸盐，以及结晶形式。

Drugs covered by this patent

Patent Metadata

Patent number
CN118159529A
Jurisdiction
CN
Classification
—
Expires
2024-06-07
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.